Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer.
作者信息
Ricardi Umberto, Giaj Levra Niccolò, Badellino Serena, Alongi Filippo
机构信息
Department of Oncology, University of Torino, Torino, Italy.
Department of Radiation Oncology, Sacro Cuore Don Calabria Cancer Care Center, Negrar-Verona, Italy.
出版信息
J Thorac Dis. 2017 Aug;9(8):2235-2237. doi: 10.21037/jtd.2017.06.133.
Abstract
摘要
相似文献
1
Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer.
J Thorac Dis. 2017 Aug;9(8):2235-2237. doi: 10.21037/jtd.2017.06.133.
2
Stereotactic ablative body radiation for oligometastatic and oligoprogressive disease.
Transl Lung Cancer Res. 2019 Feb;8(1):97-106. doi: 10.21037/tlcr.2018.09.21.
3
Consolidative Local Ablative Therapy Improves the Survival of Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated With First-Line EGFR-TKIs.
J Thorac Oncol. 2018 Sep;13(9):1383-1392. doi: 10.1016/j.jtho.2018.05.019. Epub 2018 May 29.
4
Stereotactic radiotherapy in oligometastatic cancer.
Chin Clin Oncol. 2017 Sep;6(Suppl 2):S16. doi: 10.21037/cco.2017.06.20.
5
Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
Anticancer Res. 2015 Nov;35(11):6239-45.
6
Changing equipoise in the landscape of radiation for oligometastatic lung cancer.
Transl Lung Cancer Res. 2019 Sep;8(Suppl 2):S184-S191. doi: 10.21037/tlcr.2019.07.09.
7
Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.
Clin Lung Cancer. 2017 Nov;18(6):595-606. doi: 10.1016/j.cllc.2017.03.002. Epub 2017 Mar 14.
8
Consolidative ablative radiotherapy improves outcomes in oligometastatic non-small cell lung cancer: a further step toward new evidence.
J Thorac Dis. 2018 Feb;10(2):621-624. doi: 10.21037/jtd.2018.01.19.
9
Local ablative radiotherapy for oligometastatic non-small cell lung cancer.
Radiat Oncol J. 2019 Sep;37(3):149-155. doi: 10.3857/roj.2019.00514. Epub 2019 Sep 30.
10
Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
Clin Colorectal Cancer. 2017 Mar;16(1):58-64. doi: 10.1016/j.clcc.2016.07.004. Epub 2016 Jul 18.
引用本文的文献
1
Reduction of inter-observer differences in the delineation of the target in spinal metastases SBRT using an automatic contouring dedicated system.
Radiat Oncol. 2021 Oct 9;16(1):197. doi: 10.1186/s13014-021-01924-0.
2
Epidemiology of oligometastatic non-small cell lung cancer: results from a systematic review and pooled analysis.
Transl Lung Cancer Res. 2021 Jul;10(7):3339-3350. doi: 10.21037/tlcr-20-982.
3
Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system.
Radiat Oncol. 2019 Oct 26;14(1):184. doi: 10.1186/s13014-019-1379-9.
本文引用的文献
1
Local consolidative therapy may be beneficial in patients with oligometastatic non-small cell lung cancer.
CA Cancer J Clin. 2017 Mar;67(2):89-90. doi: 10.3322/caac.21363. Epub 2017 Jan 17.
2
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.
Lancet Oncol. 2016 Dec;17(12):1672-1682. doi: 10.1016/S1470-2045(16)30532-0. Epub 2016 Oct 24.
3
Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery.
Radiat Oncol J. 2015 Dec;33(4):265-75. doi: 10.3857/roj.2015.33.4.265. Epub 2015 Dec 30.
4
Stereotactic body radiation therapy and intensity modulated radiation therapy induce different plasmatic cytokine changes in non-small cell lung cancer patients: a pilot study.
Clin Transl Oncol. 2016 Oct;18(10):1003-10. doi: 10.1007/s12094-015-1473-x. Epub 2015 Dec 21.
5
Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer.
J Thorac Oncol. 2014 Oct;9(10):1426-33. doi: 10.1097/JTO.0000000000000317.
6
An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer.
Clin Lung Cancer. 2014 Sep;15(5):346-55. doi: 10.1016/j.cllc.2014.04.003. Epub 2014 May 15.
7
Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer.
Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):880-7. doi: 10.1016/j.ijrobp.2014.04.007. Epub 2014 May 24.
8
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas.
Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):343-9. doi: 10.1016/j.ijrobp.2012.12.025. Epub 2013 Feb 22.
9
Stereotactic body radiotherapy for oligometastases.
Lancet Oncol. 2013 Jan;14(1):e28-37. doi: 10.1016/S1470-2045(12)70510-7.
10
Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects.
J Clin Invest. 2012 Oct;122(10):3718-30. doi: 10.1172/JCI61931. Epub 2012 Sep 4.
Zotero 插件